AGENUS INC Net Income (Loss) Attributable to Noncontrolling Interest
AGENUS INC (AGEN) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$17.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-07
- AGENUS INC net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$17.00K.
- AGENUS INC net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$20.00K.
- AGENUS INC net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$34.00K.
- AGENUS INC net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$3.00K.
- AGENUS INC net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$3.20M.
- AGENUS INC net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$5.06M.
- AGENUS INC net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$11.68M.
- AGENUS INC net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$10.58M.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$17.00K 10-Q · filed 2026-08-07 | -$37.00K 10-Q · filed 2026-08-07 | -$71.00K derived: sum of 3 quarters · filed 2026-08-07 | -$74.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$20.00K 10-Q · filed 2026-05-11 | -$54.00K derived: sum of 2 quarters · filed 2026-05-11 | -$57.00K derived: sum of 3 quarters · filed 2026-05-11 | -$2.11M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$37.00K derived: sum of 2 quarters · filed 2026-03-16 | -$2.09M derived: sum of 3 quarters · filed 2026-08-07 | -$3.20M 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | -$3.00K 10-Q · filed 2025-11-10 | -$2.06M derived: sum of 2 quarters · filed 2026-08-07 | -$3.16M 10-Q · filed 2025-11-10 | -$4.11M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | -$2.06M 10-Q · filed 2026-08-07 | -$3.16M 10-Q · filed 2026-08-07 | -$4.11M derived: sum of 3 quarters · filed 2026-08-07 | -$4.94M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | -$1.10M 10-Q · filed 2026-05-11 | -$2.05M derived: sum of 2 quarters · filed 2026-05-11 | -$2.88M derived: sum of 3 quarters · filed 2026-05-11 | -$4.59M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | -$947.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$1.77M derived: sum of 2 quarters · filed 2026-03-16 | -$3.49M derived: sum of 3 quarters · filed 2026-03-16 | -$5.06M 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | -$828.00K 10-Q · filed 2025-11-10 | -$2.54M derived: sum of 2 quarters · filed 2025-11-10 | -$4.11M 10-Q · filed 2025-11-10 | -$6.40M derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2024-06-30 | -$1.72M 10-Q · filed 2025-08-11 | -$3.28M 10-Q · filed 2025-08-11 | -$5.58M derived: sum of 3 quarters · filed 2026-03-16 | -$7.91M derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2024-03-31 | -$1.57M 10-Q · filed 2025-05-12 | -$3.86M derived: sum of 2 quarters · filed 2026-03-16 | -$6.19M derived: sum of 3 quarters · filed 2026-03-16 | -$10.61M derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2023-12-31 | -$2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$4.62M derived: sum of 2 quarters · filed 2026-03-16 | -$9.04M derived: sum of 3 quarters · filed 2026-03-16 | -$11.68M 10-K · filed 2026-03-16 | ||||
| 2023-09-30 | -$2.33M 10-Q · filed 2024-11-12 | -$6.75M derived: sum of 2 quarters · filed 2024-11-12 | -$9.38M 10-Q · filed 2024-11-12 | -$12.39M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | -$4.41M 10-Q · filed 2024-08-08 | -$7.05M 10-Q · filed 2024-08-08 | -$10.06M derived: sum of 3 quarters · filed 2025-03-17 | -$12.55M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | -$2.64M 10-Q · filed 2024-05-07 | -$5.65M derived: sum of 2 quarters · filed 2025-03-17 | -$8.14M derived: sum of 3 quarters · filed 2025-03-17 | -$10.94M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | -$3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$5.50M derived: sum of 2 quarters · filed 2025-03-17 | -$8.30M derived: sum of 3 quarters · filed 2025-03-17 | -$10.58M 10-K · filed 2025-03-17 | ||||
| 2022-09-30 | -$2.49M 10-Q · filed 2023-11-09 | -$5.29M derived: sum of 2 quarters · filed 2023-11-09 | -$7.57M 10-Q · filed 2023-11-09 | -$9.67M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-06-30 | -$2.80M 10-Q · filed 2023-08-08 | -$5.08M 10-Q · filed 2023-08-08 | -$7.18M derived: sum of 3 quarters · filed 2024-03-14 | -$8.45M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-03-31 | -$2.28M 10-Q · filed 2023-05-09 | -$4.38M derived: sum of 2 quarters · filed 2024-03-14 | -$5.65M derived: sum of 3 quarters · filed 2024-03-14 | -$6.35M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2021-12-31 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$3.37M derived: sum of 2 quarters · filed 2024-03-14 | -$4.07M derived: sum of 3 quarters · filed 2024-03-14 | -$4.80M 10-K · filed 2024-03-14 | ||||
| 2021-09-30 | -$1.27M 10-Q · filed 2022-11-08 | -$1.98M derived: sum of 2 quarters · filed 2022-11-08 | -$2.70M 10-Q · filed 2022-11-08 | -$2.83M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-06-30 | -$701.00K 10-Q · filed 2022-08-09 | -$1.43M 10-Q · filed 2022-08-09 | -$1.55M derived: sum of 3 quarters · filed 2023-03-16 | -$2.04M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-03-31 | -$726.00K 10-Q · filed 2022-05-10 | -$849.00K derived: sum of 2 quarters · filed 2023-03-16 | -$1.34M derived: sum of 3 quarters · filed 2023-03-16 | -$2.11M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2020-12-31 | -$123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$616.00K derived: sum of 2 quarters · filed 2023-03-16 | -$1.38M derived: sum of 3 quarters · filed 2023-03-16 | -$1.98M 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | -$493.00K 10-Q · filed 2021-11-09 | $493.00K 10-Q · filed 2020-11-09 | -$1.26M derived: sum of 2 quarters · filed 2021-11-09 | -$1.85M 10-Q · filed 2021-11-09 | $1.85M 10-Q · filed 2020-11-09 | -$8.86M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | -$764.00K 10-Q · filed 2021-08-09 | $764.00K 10-Q · filed 2020-08-10 | -$1.36M 10-Q · filed 2021-08-09 | $1.36M 10-Q · filed 2020-08-10 | -$8.37M derived: sum of 3 quarters · filed 2022-03-01 | -$7.57M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | -$597.00K 10-Q · filed 2021-05-07 | -$7.61M derived: sum of 2 quarters · filed 2022-03-01 | -$6.80M derived: sum of 3 quarters · filed 2022-03-01 | -$5.57M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | -$7.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$6.21M derived: sum of 2 quarters · filed 2022-03-01 | -$4.97M derived: sum of 3 quarters · filed 2022-03-01 | -$3.90M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $803.00K 10-Q · filed 2020-11-09 | -$803.00K 10-Q · filed 2019-11-07 | $2.04M derived: sum of 2 quarters · filed 2020-11-09 | $3.11M 10-Q · filed 2020-11-09 | -$3.11M 10-Q · filed 2019-11-07 | -$129.00K derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2019-06-30 | $1.23M 10-Q · filed 2020-08-10 | -$1.23M 10-Q · filed 2019-08-09 | $2.30M 10-Q · filed 2020-08-10 | -$2.30M 10-Q · filed 2019-08-09 | -$932.00K derived: sum of 3 quarters · filed 2021-03-16 | -$1.54M derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2019-03-31 | -$1.07M 10-Q · filed 2020-05-11 | -$2.17M derived: sum of 2 quarters · filed 2021-03-16 | -$2.77M derived: sum of 3 quarters · filed 2021-03-16 | -$3.30M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2018-12-31 | -$1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$1.70M derived: sum of 2 quarters · filed 2021-03-16 | -$2.23M derived: sum of 3 quarters · filed 2021-03-16 | -$2.35M 10-K · filed 2021-03-16 | -$2.35M 10-K · filed 2019-03-18 | |||
| 2018-09-30 | -$605.00K 10-Q · filed 2019-11-07 | -$604.89K 10-Q · filed 2018-11-07 | -$1.14M derived: sum of 2 quarters · filed 2019-11-07 | -$1.26M 10-Q · filed 2019-11-07 | -$1.26M 10-Q · filed 2018-11-07 | |||
| 2018-06-30 | -$533.00K 10-Q · filed 2019-08-09 | -$532.73K 10-Q · filed 2018-08-09 | -$653.00K 10-Q · filed 2019-08-09 | -$653.36K 10-Q · filed 2018-08-09 | ||||
| 2018-03-31 | -$121.00K 10-Q · filed 2019-05-10 | -$120.63K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |